White House looking to slash $40 B from health department
17 Apr 2025 //
REUTERS
AstraZeneca unit sued over alleged monopoly on drug Soliris
17 Apr 2025 //
REUTERS
Trump`s call to end IRA `pill penalty` marks win for pharma
17 Apr 2025 //
FIERCE PHARMA
Novartis terminates Ph 2 osteoarthritis trial testing
17 Apr 2025 //
FIERCE BIOTECH
Santhera shares updates on commercial rollout of Agamree
17 Apr 2025 //
GLOBENEWSWIRE
Ayrmid misses deadline for offer to Private Equity bid for Bluebird
17 Apr 2025 //
ENDPTS
Chime Partners Polpharma Biologics to Advance Biosimilar
17 Apr 2025 //
PRESS RELEASE
Glenmark to launch generic version of Adderall Tablets
17 Apr 2025 //
EXPRESSPHARM
Regulator bans 35 combination drugs over safety issues
17 Apr 2025 //
ECONOMICTIMES
Drugs In Development

Market Intel
